Study confirms HORIBA’s Microsemi CRP POCT aids urgent care decision making in GP practice through combined FBC & CRP

Northampton, UK – 14th December 2020 – HORIBA UK Ltd, Medical announces that Oxford Academic Health Science Network (AHSN) has recently published a study exploring use of point-of-care testing (POCT) within a busy GP group practice [1]. The study, using HORIBA Medical’s novel Microsemi CRP POC haematology analyser, aimed to relieve winter flu pressures and to meet local Clinical Commissioning Group (CCG) demands to reduce unnecessary hospital visits and admissions. Its results demonstrate tangible benefits for urgent care clinical decision making and cost savings by using this POC technology in primary care. The current pressures on health services due to COVID-19 also render the findings very relevant.

The Brookside Group Practice (Lower Earley, Berkshire) had previously introduced a new patient pathway model by creating a multidisciplinary, paramedic-led urgent care clinic, aiming to retain patients in a primary care setting where possible. Already the subject of an in-depth audit and evaluation working alongside the AHSN, the practice’s urgent care model was shown to deliver reduced waiting times, more efficient referrals, and cost savings of between 4% to 38% [1]. The introduction of pathology POCT represented the second phase of the project to further enhance their decision-making process.

Previous studies have also highlighted the benefits of using Microsemi CRP POCT in urgent care pathways to enable more rapid clinical decision-making, saving time and reducing costs, and thereby improve clinical service delivery [2]. This instrument was therefore selected for use at the Brookside urgent care unit.

The Microsemi CRP requires just 18 µL of whole blood to deliver the simultaneous measurement of full blood count (FBC), including three-part differential, and C-Reactive Protein (CRP) within four minutes. The combination of CRP, an inflammatory marker, and white blood count plus granulocyte count, helps to identify sepsis, distinguish between bacterial and viral infection and also establishes the severity of disease. To offer a full suite of POCT measurements, this analyser was placed alongside the i-STAT Alinity (Abbott) which detects blood chemistry abnormalities.

Following training, the analysers were operated by a variety of clinical staff: GPs, nursing staff and paramedics, demonstrating the ease with which the instrumentation can be operated. The study confirmed that the introduction of POCT at the GP practice fully supported the clinical decision-making process for a range of urgent care needs. It increased clinical confidence in diagnosis within the urgent care clinic leading to more appropriate patient referrals to secondary care. Indicative modelling on the costs of testing and secondary care referrals against instances where referrals were avoided established potential cost savings of over £26,000 annually.

Feedback from healthcare professionals involved in the study also confirmed that the availability of a POC test result allowed them to have a more meaningful or specific discussion with the patient about their diagnosis. Furthermore, patients tended to accept a test result more readily than the clinical opinion of the medical professional alone. Therefore, this POCT also served to improve patient experience and outcomes.

The Microsemi CRP analyser has been installed across a variety of primary and secondary care settings, including community hubs, emergency departments and assessment units where it is operated by multidisciplinary healthcare teams. In addition, CRP testing has been demonstrated to be a useful indicator of severity for COVID-19 patients [3] alongside the more general application of the instrument’s parameters in patient triage. 

“The current COVID-19 pandemic has provided a catalyst to explore different models for delivering care efficiently. This and studies like the one produced by Oxford AHSN have the potential to help shape the future of primary care,” commented Cleve Wright, Director, HORIBA Medical UK. “Our Microsemi CRP has been shown to be an invaluable POCT tool to support clinical decision making for urgent care pathways in primary care settings.” 

The full study is available at: https://www.oxfordahsn.org/wp-content/uploads/2020/11/Use-of-POC-testing-in-a-GP-Urgent-Care-Pathway-Report-Final-22-10-20.pdf

1.    Checketts G, Okhai N, Bajre M, Sharma A, Edwards A, Hart J. Introducing point of care (POC) testing in a primary care urgent care pathway to improve clinical service delivery. Oxford Academic Health Science Network (2020)
2.    McDonald C, Philpott J, Segal S, Hart J. Can using point of care blood tests in emergency paediatric units improve quality of care? Oxford Academic Health Science Network (2017)
3.    Siatka C, Eveillard M, Nishimura J, Duroux C, Ferrandi G. COVID-19 screening, prognosis and severity assessment with biomarkers for management of patients. HORIBA Medical White Paper. Published 10 April 2020

This press release is available online at: https://www.horiba.com/uk/medical/news-events/news/article/study-confirms-horibas-microsemi-crp-poct-aids-urgent-care-decision-making-in-gp-practice-through-combined-fbc-and-crp-67539/


SpeeDx Pty. Ltd. establishes US-based operation

SYDNEY, AUSTRALIA–(December 04, 2017). SpeeDx Pty. Ltd, a developer of advanced multiplex molecular...

Read More >

Mologic receives a $4.8m grant to establish the centre for advanced rapid diagnostics ("card")

Mologic is pleased to announce that we are in receipt of a grant from the Bill & Melinda Gates Found...

Read More >

UK lateral flow rapid test manufacturer Abingdon Health confirms expansion

Following a successful 2019, Abingdon Health is expanding its York-based facility, giving the compan...

Read More >

OGT enhances customer experience with new Cytocell website

Oxford, UK – 7 March 2018. Oxford Gene Technology (OGT), The Molecular Genetics Company, has launch...

Read More >